Orthofix Medical (OFIX) Shares Outstanding (Weighted Average) (2009 - 2026)

Orthofix Medical (OFIX) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $40.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 3.22% year-over-year to $40.4 million; the trailing twelve-month figure through Mar 2026 stood at $40.4 million (up 3.22% YoY), and the FY2025 full-year result was $39.6 million, up 3.85% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $40.4 million, up from $39.6 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $40.4 million in Q1 2026 and bottomed at $19898.0 in Q1 2022.
• A 5-year average of $26.2 million and a median of $37.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) sank 99.9% in 2022 and soared 186079.84% in 2023, its largest moves.
• Tracing OFIX's Shares Outstanding (Weighted Average) over 5 years: stood at $20.1 million in 2022, then surged by 83.16% to $36.7 million in 2023, then grew by 3.82% to $38.1 million in 2024, then rose by 3.85% to $39.6 million in 2025, then increased by 2.14% to $40.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $40.4 million, $39.6 million, and $39.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison